Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2019
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Cumberland Pharmaceuticals
- 19 Sep 2012 Top-line results published in a Cumberland Pharmaceuticals media release.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.